Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HER2
Pharma
Daiichi, AZ's Enhertu nabs 7th FDA nod in breast cancer first
The FDA has cleared AZ and Daiichi Sankyo's Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer after one or more endocrine therapies
Kevin Dunleavy
Jan 28, 2025 10:19am
Pfizer's Ibrance scores in double-positive breast cancer
Dec 12, 2024 8:15am
Jazz's HER2 bispecific snags FDA nod to rival Enhertu
Nov 21, 2024 7:53am
Enhertu stalls as AZ, Daiichi navigate 'harder yards' for ADC
Jul 25, 2024 11:12am
Boehringer Ingelheim preps for 2 upcoming oncology launches
Jun 10, 2024 8:20am
ASCO: Enhertu looks to make history again in HER2-ultralow group
Jun 2, 2024 8:00am